# Safety Study of R(+)Pramipexole to Treat Early Alzheimer's Disease

> **NCT01388478** · PHASE2 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 20 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** R-pramipexole

## Key facts

- **NCT ID:** NCT01388478
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2014-01
- **Final completion:** 2014-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-10-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01388478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01388478, "Safety Study of R(+)Pramipexole to Treat Early Alzheimer's Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01388478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*